RADIESSE® Voice is provided in a sterile ready-to-use syringe. No skin allergy testing is required. Because the amount of filling or augmentation can be easily controlled through direct application, RADIESSE Voice is easy to place and convenient to use.
The injection volume and location should conform to the following recommendations:

• The vocal fold injections should be at the level of the vocal process.
• The depth of the vocal fold injection should be approximately 5-7 mm.
• The vocal fold injection volume should be done strictly on immediate clinical observation, and approximately 10-15% over correction is recommended.

RADIESSE Voice may be administered by:

• In-office Trans-Oral Injection
• In-Office Percutaneous Injection
• Operating Room Trans-Oral Injection

In-office Trans-Oral Injection

• Topical anesthesia (drip onto larynx)
• Connect needle (notice alignment of green dot) See Figures 1 and 2
• Prime needle (~0.18 cc dead volume)
• Note start and end volume to determine volume injected

In-office Percutaneous Injection

• Transnasal endoscopic guidance
• Local anesthesia
• Needle has non-coring “Huber” tip
• Prime needle
• Note start and end volume to determine volume injected

Operating Room Trans-Oral Injection

• Direct laryngoscopy or micro-laryngoscopy
• Similar to autologeous fat injections but only with a 10-15% over correction